Published ahead of print on August 13, 2003, doi:10.1164/rccm.200302-219OC
American Journal of Respiratory and Critical Care Medicine Vol 168. pp. 1084-1090, (2003)
© 2003 American Thoracic Society
Prognostic Value of Desaturation during a 6-Minute Walk Test in Idiopathic Interstitial Pneumonia
Vibha N. Lama,
Kevin R. Flaherty,
Galen B. Toews,
Thomas V. Colby,
William D. Travis,
Qi Long,
Susan Murray,
Ella A. Kazerooni,
Barry H. Gross,
Joseph P. Lynch, III and
Fernando J. Martinez
Division of Pulmonary and Critical Care Medicine and Department of Radiology, University of Michigan Health System; Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan; and the Armed Forces Institute of Pathology, Mayo Clinic, Scottsdale, Arizona
Correspondence and requests for reprints should be addressed to Fernando J. Martinez, M.D., M.S., 1500 East Medical Center Drive, 3916 Taubman Center, Ann Arbor, MI 481090360. E-mail: fmartine{at}umich.edu
Exercise-induced hypoxia is an index of the severity of interstitial lung disease. We hypothesized that desaturation during a 6-minute walk test would predict mortality for patients with usual interstitial pneumonia (n = 83) and nonspecific interstitial pneumonia (n = 22). Consecutive patients with biopsy-proven disease performed a 6-minute walk test between January 1996 and December 2001. Desaturation was defined as a fall in oxygen saturation to 88% or less during the 6-minute walk test. Desaturation was common (44 of 83 usual interstitial pneumonia and 8 of 22 nonspecific interstitial pneumonia; chi square, p = 0.39). Patients with usual interstitial pneumonia or nonspecific interstitial pneumonia who desaturated had a significantly higher mortality than patients who did not desaturate (respective log-rank tests, p = 0.0018, p = 0.0089). In patients with usual interstitial pneumonia, the presence of desaturation was associated with an increased hazard of death (hazard ratio, 4.2; 95% confidence interval, 1.40, 12.56; p = 0.01) after adjusting for age, sex, smoking, baseline diffusion capacity for carbon monoxide, FVC, and resting saturation. We conclude that knowledge of desaturation during a 6-minute walk test adds prognostic information for patients with usual interstitial pneumonia and nonspecific interstitial pneumonia.
Key Words: 6-minute walk test usual interstitial pneumonia nonspecific interstitial pneumonia
This article has been cited by other articles:

|
 |

|
 |
 
T J Corte, S J Wort, M A Gatzoulis, P Macdonald, D M Hansell, and A U Wells
Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension
Thorax,
October 1, 2009;
64(10):
883 - 888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Swigris, J. Swick, F. S. Wamboldt, D. Sprunger, R. du Bois, A. Fischer, G. P. Cosgrove, S. K. Frankel, E. R. Fernandez-Perez, D. Kervitsky, et al.
Heart Rate Recovery After 6-Min Walk Test Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis
Chest,
September 1, 2009;
136(3):
841 - 848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J J Swigris, X Zhou, F S Wamboldt, R du Bois, R Keith, A Fischer, G P Cosgrove, S K Frankel, D Curran-Everett, and K K Brown
Exercise peripheral oxygen saturation (Spo2) accurately reflects arterial oxygen saturation (Sao2) and predicts mortality in systemic sclerosis
Thorax,
July 1, 2009;
64(7):
626 - 630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. U. Wells, V. Steen, and G. Valentini
Pulmonary complications: one of the most challenging complications of systemic sclerosis
Rheumatology,
June 1, 2009;
48(suppl_3):
iii40 - iii44.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Prasse, C. Probst, E. Bargagli, G. Zissel, G. B. Toews, K. R. Flaherty, M. Olschewski, P. Rottoli, and J. Muller-Quernheim
Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
April 15, 2009;
179(8):
717 - 723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Antoniou, G. Margaritopoulos, F. Economidou, and N. M. Siafakas
Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement
Eur. Respir. J.,
April 1, 2009;
33(4):
882 - 896.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Moeller, S. E. Gilpin, K. Ask, G. Cox, D. Cook, J. Gauldie, P. J. Margetts, L. Farkas, J. Dobranowski, C. Boylan, et al.
Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
April 1, 2009;
179(7):
588 - 594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Fell, L. X. Liu, C. Motika, E. A. Kazerooni, B. H. Gross, W. D. Travis, T. V. Colby, S. Murray, G. B. Toews, F. J. Martinez, et al.
The Prognostic Value of Cardiopulmonary Exercise Testing in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
March 1, 2009;
179(5):
402 - 407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kreider and R. M. Kotloff
Selection of Candidates for Lung Transplantation
Proceedings of the ATS,
January 15, 2009;
6(1):
20 - 27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Lynch III
Idiopathic Pulmonary Fibrosis, Nonspecific Interstitial Pneumonia/Fibrosis, and Sarcoidosis
ACCP Pulmonary Med Brd Rev,
January 1, 2009;
25(0):
635 - 686.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kim and K. C. Meyer
Review: Therapies for interstitial lung disease: past, present and future
Therapeutic Advances in Respiratory Disease,
October 1, 2008;
2(5):
319 - 338.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Casanova, C. Cote, J. M. Marin, V. Pinto-Plata, J. P. de Torres, A. Aguirre-Jaime, C. Vassaux, and B. R. Celli
Distance and Oxygen Desaturation During the 6-min Walk Test as Predictors of Long-term Mortality in Patients With COPD
Chest,
October 1, 2008;
134(4):
746 - 752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Shin, K. S. Lee, M. P. Chung, J. Han, Y. A Bae, T. S. Kim, and M. J. Chung
Prognostic Determinants among Clinical, Thin-Section CT, and Histopathologic Findings for Fibrotic Idiopathic Interstitial Pneumonias: Tertiary Hospital Study1
Radiology,
October 1, 2008;
249(1):
328 - 337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A U Wells, N Hirani, and on behalf of the BTS Interstitial Lung Disease Gui
Interstitial lung disease guideline
Thorax,
September 1, 2008;
63(Suppl_5):
v1 - v58.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Shin, K. S. Lee, M. P. Chung, J. Han, Y. A Bae, T. S. Kim, and M. J. Chung
Prognostic Determinants among Clinical, Thin-Section CT, and Histopathologic Findings for Fibrotic Idiopathic Interstitial Pneumonias: Tertiary Hospital Study
Radiology,
August 5, 2008;
(2008)
2483071378.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. M. Bourbonnais and L. Samavati
Clinical predictors of pulmonary hypertension in sarcoidosis
Eur. Respir. J.,
August 1, 2008;
32(2):
296 - 302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Han, S. Murray, C. D. Fell, K. R. Flaherty, G. B. Toews, J. Myers, T. V. Colby, W. D. Travis, E. A. Kazerooni, B. H. Gross, et al.
Sex differences in physiological progression of idiopathic pulmonary fibrosis
Eur. Respir. J.,
June 1, 2008;
31(6):
1183 - 1188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Strange and J. R. Seibold
Scleroderma Lung Disease: "If You Don't Know Where You Are Going, Any Road Will Take You There"
Am. J. Respir. Crit. Care Med.,
June 1, 2008;
177(11):
1178 - 1179.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A E Holland, C J Hill, M Conron, P Munro, and C F McDonald
Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease
Thorax,
June 1, 2008;
63(6):
549 - 554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Giannakoulas, T. D. Karamitsos, G. Pitsiou, and H. I. Karvounis
Right ventricular dysfunction and functional limitation in idiopathic pulmonary fibrosis
Eur. Respir. J.,
January 1, 2008;
31(1):
219 - 220.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Han, V. V. McLaughlin, G. J. Criner, and F. J. Martinez
Pulmonary Diseases and the Heart
Circulation,
December 18, 2007;
116(25):
2992 - 3005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Zisman, A. S. Karlamangla, D. J. Ross, M. P. Keane, J. A. Belperio, R. Saggar, J. P. Lynch III, A. Ardehali, and J. Goldin
High-Resolution Chest CT Findings Do Not Predict the Presence of Pulmonary Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Chest,
September 1, 2007;
132(3):
773 - 779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Noth and F. J. Martinez
Recent Advances in Idiopathic Pulmonary Fibrosis
Chest,
August 1, 2007;
132(2):
637 - 650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Baughman, B. K. Sparkman, and E. E. Lower
Six-Minute Walk Test and Health Status Assessment in Sarcoidosis
Chest,
July 1, 2007;
132(1):
207 - 213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Flaherty, A.-C. Andrei, T. E. King Jr., G. Raghu, T. V. Colby, A. Wells, N. Bassily, K. Brown, R. du Bois, A. Flint, et al.
Idiopathic Interstitial Pneumonia: Do Community and Academic Physicians Agree on Diagnosis?
Am. J. Respir. Crit. Care Med.,
May 15, 2007;
175(10):
1054 - 1060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Nathan, P. W. Noble, and R. M. Tuder
Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension: Connecting the Dots
Am. J. Respir. Crit. Care Med.,
May 1, 2007;
175(9):
875 - 880.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. U. Wells and C. M. Hogaboam
Update in Diffuse Parenchymal Lung Disease 2006
Am. J. Respir. Crit. Care Med.,
April 1, 2007;
175(7):
655 - 660.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Fell and F. J. Martinez
The Impact of Pulmonary Arterial Hypertension on Idiopathic Pulmonary Fibrosis
Chest,
March 1, 2007;
131(3):
641 - 643.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hamada, S. Nagai, S. Tanaka, T. Handa, M. Shigematsu, T. Nagao, M. Mishima, M. Kitaichi, and T. Izumi
Significance of Pulmonary Arterial Pressure and Diffusion Capacity of the Lung as Prognosticator in Patients With Idiopathic Pulmonary Fibrosis
Chest,
March 1, 2007;
131(3):
650 - 656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Dal Corso, S. R. Duarte, J. A. Neder, C. Malaguti, M. B. de Fuccio, C. A. de Castro Pereira, and L. E. Nery
A step test to assess exercise-related oxygen desaturation in interstitial lung disease
Eur. Respir. J.,
February 1, 2007;
29(2):
330 - 336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Palange, S. A. Ward, K-H. Carlsen, R. Casaburi, C. G. Gallagher, R. Gosselink, D. E. O'Donnell, L. Puente-Maestu, A. M. Schols, S. Singh, et al.
Recommendations on the use of exercise testing in clinical practice
Eur. Respir. J.,
January 1, 2007;
29(1):
185 - 209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. O. Villalba, P. D. Sampaio-Barros, M. C. Pereira, E. M. F. P. Cerqueira, C. A. Leme Jr, J. F. Marques-Neto, and I. A. Paschoal
Six-Minute Walk Test for the Evaluation of Pulmonary Disease Severity in Scleroderma Patients
Chest,
January 1, 2007;
131(1):
217 - 222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O.J. Dempsey, K.M. Kerr, L. Gomersall, H. Remmen, and G.P. Currie
Idiopathic pulmonary fibrosis: an update
QJM,
October 1, 2006;
99(10):
643 - 654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Flaherty, A.-C. Andrei, S. Murray, C. Fraley, T. V. Colby, W. D. Travis, V. Lama, E. A. Kazerooni, B. H. Gross, G. B. Toews, et al.
Idiopathic Pulmonary Fibrosis: Prognostic Value of Changes in Physiology and Six-Minute-Walk Test
Am. J. Respir. Crit. Care Med.,
October 1, 2006;
174(7):
803 - 809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Lederer, S. M. Arcasoy, J. S. Wilt, F. D'Ovidio, J. R. Sonett, and S. M. Kawut
Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
September 15, 2006;
174(6):
659 - 664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Croxton, W. C. Bailey, and for the NHLBI Working Group on Long-term Oxygen Tr
Long-term Oxygen Treatment in Chronic Obstructive Pulmonary Disease: Recommendations for Future Research: An NHLBI Workshop Report
Am. J. Respir. Crit. Care Med.,
August 15, 2006;
174(4):
373 - 378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Martinez and M. P. Keane
Update in diffuse parenchymal lung diseases 2005.
Am. J. Respir. Crit. Care Med.,
May 15, 2006;
173(10):
1066 - 1071.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Lettieri, S. D. Nathan, S. D. Barnett, S. Ahmad, and A. F. Shorr
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Chest,
March 1, 2006;
129(3):
746 - 752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Raghu, S. T.-Y. Yang, C. Spada, J. Hayes, and C. A. Pellegrini
Sole Treatment of Acid Gastroesophageal Reflux in Idiopathic Pulmonary Fibrosis: A Case Series
Chest,
March 1, 2006;
129(3):
794 - 800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Martinez
Idiopathic Interstitial Pneumonias: Usual Interstitial Pneumonia versus Nonspecific Interstitial Pneumonia.
Proceedings of the ATS,
January 1, 2006;
3(1):
81 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Kim, H. R. Collard, and T. E. King Jr.
Classification and natural history of the idiopathic interstitial pneumonias.
Proceedings of the ATS,
January 1, 2006;
3(4):
285 - 292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Martinez and K. Flaherty
Pulmonary function testing in idiopathic interstitial pneumonias.
Proceedings of the ATS,
January 1, 2006;
3(4):
315 - 321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Demedts, J. Behr, R. Buhl, U. Costabel, R. Dekhuijzen, H. M. Jansen, W. MacNee, M. Thomeer, B. Wallaert, F. Laurent, et al.
High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis.
N. Engl. J. Med.,
November 24, 2005;
353(21):
2229 - 2242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. C. Johnson and G. Raghu
Clinical trials in idiopathic pulmonary fibrosis: a word of caution concerning choice of outcome measures
Eur. Respir. J.,
November 1, 2005;
26(5):
755 - 758.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Raghu
Poor Choice of Primary Outcome in a Clinical Trial of Pirfenidone in Patients with IPF
Am. J. Respir. Crit. Care Med.,
November 1, 2005;
172(9):
1229 - 1230.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Nathan
Therapeutic Intervention: Assessing the Role of the International Consensus Guidelines
Chest,
November 1, 2005;
128(5_suppl_1):
533S - 539S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W. Noble, L. Tanoue, and R. Homer
Case Study Review
Chest,
November 1, 2005;
128(5_suppl_1):
540S - 546S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Strange
Treatment for Secondary Pulmonary Hypertension
Chest,
October 1, 2005;
128(4):
1897 - 1898.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Eaton, P. Young, D. Milne, and A. U. Wells
Six-Minute Walk, Maximal Exercise Tests: Reproducibility in Fibrotic Interstitial Pneumonia
Am. J. Respir. Crit. Care Med.,
May 15, 2005;
171(10):
1150 - 1157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. du Bois
Is Idiopathic Pulmonary Fibrosis Now Treatable?
Am. J. Respir. Crit. Care Med.,
May 1, 2005;
171(9):
939 - 940.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Azuma, T. Nukiwa, E. Tsuboi, M. Suga, S. Abe, K. Nakata, Y. Taguchi, S. Nagai, H. Itoh, M. Ohi, et al.
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
May 1, 2005;
171(9):
1040 - 1047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J J Egan, F J Martinez, A U Wells, and T Williams
Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification
Thorax,
April 1, 2005;
60(4):
270 - 273.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Jegal, D. S. Kim, T. S. Shim, C.-M. Lim, S. Do Lee, Y. Koh, W. S. Kim, W. D. Kim, J. S. Lee, W. D. Travis, et al.
Physiology Is a Stronger Predictor of Survival than Pathology in Fibrotic Interstitial Pneumonia
Am. J. Respir. Crit. Care Med.,
March 15, 2005;
171(6):
639 - 644.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Nathan
Lung Transplantation: Disease-Specific Considerations for Referral
Chest,
March 1, 2005;
127(3):
1006 - 1016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. S. Hallstrand, L. J. Boitano, W. C. Johnson, C. A. Spada, J. G. Hayes, and G. Raghu
The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis
Eur. Respir. J.,
January 1, 2005;
25(1):
96 - 103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Swigris, W. G. Kuschner, J. L. Kelsey, and M. K. Gould
Idiopathic Pulmonary Fibrosis: Challenges and Opportunities for the Clinician and Investigator
Chest,
January 1, 2005;
127(1):
275 - 283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Flaherty, T. E. King Jr., G. Raghu, J. P. Lynch III, T. V. Colby, W. D. Travis, B. H. Gross, E. A. Kazerooni, G. B. Toews, Q. Long, et al.
Idiopathic Interstitial Pneumonia: What Is the Effect of a Multidisciplinary Approach to Diagnosis?
Am. J. Respir. Crit. Care Med.,
October 15, 2004;
170(8):
904 - 910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Tuberculosis, Lung Infections, Interstitial Lung Disease, Social Issues and Journalology in AJRCCM 2003
Am. J. Respir. Crit. Care Med.,
January 15, 2004;
169(2):
288 - 300.
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society
|
|
|